GE HealthCare Technologies Inc.

Valuation Analysis

About the Company

GE HealthCare Technologies Inc. en bref

GE HealthCare Technologies Inc. (GEHC) is currently trading at 53,69 € with a market capitalization of 24,4 Md €. The trailing P/E ratio stands at 14.77x, with a forward P/E of 11.48x. The 52-week range spans from 51,22 € to 78,26 €; the current price is 31.4% below the yearly high. Year-over-year revenue growth stands at +7.4%. The net profit margin stands at 9.1%.

💰 Dividende

GE HealthCare Technologies Inc. currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

18 analystes évaluent GE HealthCare Technologies Inc. (GEHC) au consensus : Acheter. L'objectif de cours moyen est de 69,50 €, soit un potentiel de +29.44% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 56,66 € à 85,43 €.

GE HealthCare Technologies Inc. : la thèse d'investissement en détail

GE HealthCare Technologies Inc. (GEHC) operates in the Healthcare — specifically Medical Devices — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Wall Street consensus sits at Buy with an average price target implying roughly 29.44% upside from current levels — analyst sentiment is firmly constructive. Our valuation screen flags the stock as undervalued relative to its fundamentals — multiples are running below where the cash flow profile would normally justify.

À surveiller

• The forward P/E of 11.48x is meaningfully below the trailing 14.77x — analysts expect earnings to step up; the next earnings release is the test.
• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The analyst consensus price target implies 29.44% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Profil de risque

The data points to relatively defensive market behavior.

Trading Data

Related Stocks in the Same Sector

Where can I buy GE HealthCare Technologies Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.